On the comeback trail, GSK's Blenrep scores thumbs-up from Europe's CHMP
Europe’s Committee for Medicinal Products for Human Use has recommended GSK's Blenrep for approval for patients with relapsed or refractory multiple myeloma. The nod was one of several decisions made by the committee this week.
Europe’s Committee for Medicinal Products for Human Use has recommended GSK's Blenrep for approval for patients with relapsed or refractory multiple myeloma. The nod was one of several decisions made by the committee this week.
